Leef Brands (LEEEF) Non-cash Items (2023 - 2026)

Leef Brands' (LEEEF) quarterly Non-cash Items came in at $690905.0 in Q1 2026, up 7.23% quarter-over-quarter from $644330.0 in Q4 2025.

Leef Brands (LEEEF) Non-cash Items (2023 - 2026) Analysis & Trends

Leef Brands has disclosed Non-cash Items across 4 years of filings, most recently posting $690905.0 for Q1 2026.

  • Non-cash Items for Q1 2026 came in at $690905.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $690905.0 (changed N/A YoY), and the FY2025 annual result was $644330.0, down 12.98% from the prior year.
  • Non-cash Items came in at $690905.0 for Q1 2026 at Leef Brands, up from $644330.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $740452.0 in Q4 2024 to a low of $125997.0 in Q4 2023.
  • The 4-year median for Non-cash Items is $667617.5 (2025), against an average of $550421.0.
  • Across the five-year window, Non-cash Items soared 487.67% in 2024 and retreated 12.98% in 2025, its largest moves.
  • Leef Brands' Non-cash Items stood at $125997.0 in 2023, then jumped by 487.67% to $740452.0 in 2024, then dropped by 12.98% to $644330.0 in 2025, then rose by 7.23% to $690905.0 in 2026.
  • The last three Non-cash Items figures came in at $690905.0 (Q1 2026), $644330.0 (Q4 2025), and $740452.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Leef Brands - - 4.62 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 690,905.00
Mar 31, 2026 690,905.00
Dec 31, 2025 644,330.00
Dec 31, 2025 644,330.00
Dec 31, 2024 740,452.00
Dec 31, 2024 740,452.00
Dec 31, 2023 125,997.00
Dec 31, 2023 125,997.00